Debate: Should you use third-line (salvage) therapy to manage patients with advanced NSCLC? - Yes
Debate: Should you use third-line (salvage) therapy to manage patients with advanced NSCLC? - No
Debate: Should immunotherapy be used alone? - Yes, immunotherapy could be used alone
Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Sometimes
Options for Third-line Therapy in Metastatic CRC
Debate: Should immunotherapy be used alone? - No, only in combination with chemotherapy
Second- & Third-line options after Chemotherapy or I/O
What’s Next After I Use Checkpoint Inhibitor Combination Therapy First-line in Advanced NSCLC?
Is Immunotherapy Combo a Better Option in Advanced NSCLC? - Medpage Today
Debate: What is the optimal timing for EGFR-targeted therapy? - Favor frontline therapy
mCRC: Options for Third-Line Therapy
Third-Line Therapy for Metastatic Colorectal Cancer
Debate: Optimal Approach for Stage I NSCLC - Surgery
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC
Considering a Clinical Trial for Lung Cancer Treatment? What You Should Know
Maintenance Paradigm in Non-squamous NSCLC
Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management Session 1
Debate: Adjuvant EGFR-directed therapy for patients with early stage NSCLC? - Yes
Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises
The Future of Lung Cancer Management
